MedTrace Logo

Dissecting the Genetics of Fetal Alcohol Spectrum Disorders

NCT04072809 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 751

Last updated 2023-05-06

No results posted yet for this study

Summary

The purpose of this study is to help scientists understand why some people who were exposed to alcohol in the womb have special facial features but other people do not. This study will test if genetics (or DNA) explains these differences. We hope this will help improve treatments and interventions for people with fetal alcohol spectrum disorders (FASD).

Participants in this study (or their parents or legal guardians) will be asked to:

* Answer some questions about themselves. These questions ask about their demographic background (such as gender, race, ethnicity, income, and education), their health history, and their mother's health during her pregnancy with them (if that information is known).
* Speak with study staff briefly by phone or video chat to confirm enrollment in the study and ask any questions they have.
* Take photographs of their face.
* Provide a saliva sample for genetic research.

Participants can complete the study at home from anywhere in the world. The questions can be answered online, over the phone, or on paper. Adopted families are welcome to enroll. The study pays for all shipping costs.

Conditions

  • Fetal Alcohol Spectrum Disorders

Interventions

OTHER

No intervention

This study does not involve any interventions.

Sponsors & Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • Indiana University

    lead OTHER

Principal Investigators

  • Tatiana Foroud · Indiana University

  • Leah Wetherill · Indiana University

Eligibility

Min Age
1 Month
Max Age
110 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-06
Primary Completion
2023-05-01
Completion
2023-05-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04072809 on ClinicalTrials.gov